Tag: Pharma acquisition news

Idera Pharmaceuticals acquires rare orphan disease company Aceragen

businessnewstoday- October 2, 2022

Idera Pharmaceuticals, a US-based biopharma company, has acquired Aceragen, a biotechnology company focused on developing drugs for rare, orphan pulmonary,  and rheumatic diseases. The acquisition ... Read More

Torrent Pharmaceuticals to acquire dermatology company Curatio Healthcare for Rs 20bn

businessnewstoday- September 28, 2022

Indian pharma company Torrent Pharmaceuticals has agreed to acquire cosmetic dermatology company Curatio Healthcare (I) Private Limited for INR 2,000 crores, in a move to ... Read More

[German] Pure Hydrogen buys 24 perc...
[German] Pure Hydrogen buys 24 percent of H2X Global fuel cell vehicle company

Sartorius to acquire recombinant albumin-based solutions provider Albumedix

- August 9, 2022

Sartorius Group, a German pharma and lab equipment supplier, through its French listed subgroup Sartorius Stedim Biotech, has agreed to acquire privately-held biotech company Albumedix ... Read More

Pfizer to acquire Oxbryta developer Global Blood Therapeutics for $5.4bn

- August 8, 2022

Pfizer has agreed to acquire Global Blood Therapeutics (GBT), a publicly-listed American biopharma company, in a deal worth around $5.4 billion with an aim to ... Read More

Gilead Sciences to acquire British biotech company MiroBio for $405m

- August 6, 2022

Gilead Sciences has agreed to acquire MiroBio, a clinical-stage British biotech company, in an all-cash deal worth around $405 million in a move to gain ... Read More

Amgen to acquire American biopharma company ChemoCentryx for $3.7bn

- August 4, 2022

Amgen has agreed to acquire ChemoCentryx, a biopharma company engaged in developing medications for inflammatory and autoimmune diseases and cancer, in an all-cash deal worth ... Read More

AstraZeneca to acquire US biotech firm TeneoTwo for up to $1.27bn

- July 6, 2022

UK-based pharma giant AstraZeneca has signed a deal worth up to $1.27 billion to acquire American biotech company TeneoTwo in a move to bolster its ... Read More

Isleworth Healthcare scraps $602m merger deal with biopharma firm Cytovia

- July 2, 2022

Isleworth Healthcare Acquisition Corporation and Florida-based biopharma company Cytovia Holdings have scrapped their previously announced merger deal worth $602 million. The deal between the special ... Read More

Ipsen to acquire American biopharma company Epizyme for $247m

- June 27, 2022

French pharma company Ipsen has agreed to acquire Epizyme, a Massachusetts-based commercial-stage biopharma company for an initial consideration of $247 million. Epizyme, which is listed ... Read More

Pfizer to invest $95m in French specialty vaccine company Valneva

- June 22, 2022

US pharma giant Pfizer said that it will invest $95 million in Valneva, a French specialty vaccine company, for an 8.1% stake. The two firms ... Read More